FDA Investigator: Lakshmi Ran Narasimhan
- Lakshmi Ran Narasimhan first started conducting FDA inspections in 2012, with the last inspection in 2018. Over that time, Lakshmi Ran Narasimhan has conducted 7 inspections at 7 companies across 6 sites.
Get Lakshmi Ran Narasimhan's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.
Documents
Upon purchase, you will receive an email with a link to immediately download the documents.
FDA 483 Intas Biopharmaceuticals, Ahmedabad | July 2015
Available Now - $199
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Exelead, Inc., Indianapolis | 2018
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Biocon Limited, Bangalore | 2017
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Eli Lilly SA Irish Branch, Kinsale, County Cork | 2014
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Sigma-Tau Pharmasource, Inc., Indianapolis | 2013
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
FDA 483 Novartis Pharmaceuticals Corporation, Vacaville | 2012
Out-of-stock
Lakshmi Ran Narasimhan
Human Drug Form 483
Co-Investigators (15)
- Bo Chi, FDA Investigator
- Jazmine N. Still, FDA Investigator
- Lindsey J. Brown, FDA Investigator
- Michael Shanks, FDA Investigator
- Reyes Candau-Chacon, FDA Investigator
- Daniel J. Roberts, FDA Investigator
- Kalavati C. Suvarna, FDA Investigator
- Meisha R. Waters, FDA Investigator
- Larry K. Austin, FDA Investigator
- Colleen Thomas, FDA Investigator
- Meisha R. Sampson, FDA Investigator
- Patricia F. Hughes Troost, FDA Investigator
- Lance M. De Souza, FDA Investigator
- Hughes Troost, Patricia F, FDA Investigator
- De Souza, Lance M, FDA Investigator